🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A multicenter, randomized, open-label, active-controlled Phase 3 study for ...
Status
Completed
Location
Research Site
Start Date
2016-07
Trial ID
NCT02865850
Treatments Being Tested
This is a Phase 2, randomized, open-label study to evaluate vadadustat vers...
Status
Terminated
Location
Research Site
Start Date
2017-05-02
Trial ID
NCT03140722
Treatments Being Tested
The purpose of this study is to evaluate the hemoglobin response (efficacy)...
Status
Completed
Location
Multiple Locations
Start Date
2013-07-23
Trial ID
NCT01906489
This is a Phase 2 open-label efficacy, safety, and pharmacokinetic/pharmaco...
Status
Completed
Location
Research Site
Start Date
2019-01-31
Trial ID
NCT03799627
Treatments Being Tested
A multicenter, randomized, open-label, active-controlled Phase 3 study for ...
Status
Completed
Location
Research Site
Start Date
2016-02
Trial ID
NCT02680574
Treatments Being Tested
This is a healthy volunteers study to assess the bioequivalence of vadadust...
Status
Completed
Location
Paraxel International
Start Date
2018-08-03
Trial ID
NCT03657290
Treatments Being Tested
The primary purpose of this study is to compare the PK parameters of a sing...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02412449
The main purpose of this study is to evaluate the effect of single oral the...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02062203
Treatments Being Tested
The purpose of this study is to evaluate the hemoglobin response (efficacy)...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-10
Trial ID
NCT02260193
A multicenter, randomized, open-label, active-controlled Phase 3 study for ...
Status
Completed
Location
Research Site
Start Date
2016-08
Trial ID
NCT02892149
Treatments Being Tested